Back
Noodles & Co. 10K Form
Buy
62
NDLS
Noodles & Co.
Last Price:
$0.95
Seasonality Move:
9.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | NDLS/Noodles & Co. Quarterly |
| 2023-11-08 | 10Q | NDLS/Noodles & Co. Quarterly |
| 2023-08-10 | 10Q | NDLS/Noodles & Co. Quarterly |
| 2023-05-11 | 10Q | NDLS/Noodles & Co. Quarterly |
| 2022-11-04 | 10Q | NDLS/Noodles & Co. Quarterly |
| 2022-07-28 | 10Q | NDLS/Noodles & Co. Quarterly |
Receive NDLS News And Ratings
See the #1 stock for the next 7 days that we like better than NDLS
NDLS Financial Statistics
Sales & Book Value
| Annual Sales: | $493.3M |
|---|---|
| Cash Flow: | $1.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.83 |
| Price / Book: | 15.17 |
Profitability
| EPS (TTM): | -0.98710 |
|---|---|
| Net Income (TTM): | $-45.5M |
| Gross Margin: | $44.9M |
| Return on Equity: | -1238.45% |
| Return on Assets: | -14.57% |
Noodles & Co. Earnings Forecast
Key Noodles & Co. Financial Ratios
-
The Gross Profit Margin over the past 15 years for NDLS is 9.09%.
-
The Selling, General & Administrative Expenses for NDLS have been equal to 10.30% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of NDLS is -7.34% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 8 years.
Noodles & Co. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Hotels, Restaurants & Leisure |
| Sector: | Consumer Discretionary |
| Current Symbol: | NDLS |
| CUSIP: | 65540B |
| Website: | noodles.com |
Debt
| Debt-to-Equity Ratio: | -7.1 |
|---|---|
| Current Ratio: | 0.34 |
| Quick Ratio: | 0.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NDLS Technical Analysis vs Fundamental Analysis
Buy
62
Noodles & Co. (NDLS)
is a Buy
Is Noodles & Co. a Buy or a Sell?
-
Noodles & Co. stock is rated a BuyThe current Noodles & Co. [NDLS] share price is $0.94. The Score for NDLS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.